Patrick G Sullivan Selected Research

2,4-Dinitrophenol (2,4 Dinitrophenol)

1/2021	Mitochondria exert age-divergent effects on recovery from spinal cord injury.
10/2018	Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice.
1/2009	Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury.
10/2004	The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick G Sullivan Research Topics

Disease

26	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 08/2002
23	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 06/2003
18	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 04/2002
10	Contusions 01/2022 - 02/2005
9	Inflammation (Inflammations) 01/2022 - 01/2006
5	Brain Injuries (Brain Injury) 12/2021 - 09/2002
5	Parkinson Disease (Parkinson's Disease) 01/2019 - 05/2004
4	Insulin Resistance 01/2021 - 01/2019
4	Parkinsonian Disorders (Parkinsonism) 01/2013 - 02/2008
4	Alzheimer Disease (Alzheimer's Disease) 03/2011 - 05/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2004
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 05/2021
2	Ischemic Stroke 01/2022 - 05/2021
2	Reperfusion Injury 01/2022 - 05/2021
2	Edema (Dropsy) 05/2021 - 04/2011
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2015
2	Obesity 01/2019 - 01/2018
2	Cognitive Dysfunction 01/2019 - 01/2011
2	Wounds and Injuries (Trauma) 07/2014 - 08/2009
2	Neuroinflammatory Diseases 06/2013 - 01/2009
1	Thrombophilia 05/2022
1	Dementia (Dementias) 04/2022
1	Neuroblastoma 01/2022
1	Atrophy 12/2021
1	Stroke (Strokes) 05/2021
1	Infarction (Infarctions) 05/2021
1	Triple Negative Breast Neoplasms 04/2021
1	Neoplasms (Cancer) 04/2021
1	Leukoencephalopathies 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Body Weight (Weight, Body) 01/2019
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2018
1	Pain (Aches) 01/2018
1	Tics (Tic) 01/2018
1	Trigeminal Nerve Injuries 01/2018

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2003
8	Pioglitazone (Actos)FDA Link 12/2021 - 03/2007
5	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022 - 05/2007
5	CalciumIBA 01/2021 - 04/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2008
4	AntioxidantsIBA 01/2022 - 01/2009
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 02/2009
4	2,4-Dinitrophenol (2,4 Dinitrophenol)IBA 01/2021 - 10/2004
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
3	MicroRNAs (MicroRNA)IBA 03/2021 - 03/2015
3	Free RadicalsIBA 01/2021 - 06/2007
3	LipidsIBA 01/2021 - 07/2004
3	CytokinesIBA 01/2019 - 01/2011
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2009
3	(melle-4)cyclosporinIBA 01/2018 - 04/2007
3	Dopamine (Intropin)FDA LinkGeneric 12/2017 - 03/2007
3	3-nitrotyrosineIBA 12/2016 - 06/2007
3	Trichloroethylene (Trichloroethene)IBA 03/2012 - 02/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2011 - 07/2004
2	Insulin (Novolin)FDA Link 04/2022 - 06/2008
2	LigandsIBA 01/2022 - 05/2021
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2020
2	mirabegronIBA 01/2021 - 01/2020
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021 - 02/2008
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 05/2007
2	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 01/2019
2	KetonesIBA 01/2015 - 06/2008
2	Phosphotransferases (Kinase)IBA 01/2013 - 01/2011
2	Neuroprotective AgentsIBA 02/2011 - 06/2008
2	Adenosine Triphosphate (ATP)IBA 08/2009 - 05/2007
2	NitrogenIBA 02/2009 - 08/2004
2	SilverIBA 03/2008 - 02/2005
1	Thrombin FDA Link 05/2022
1	Thromboplastin (Tissue Factor)IBA 05/2022
1	ceric oxide (cerium dioxide)IBA 01/2022
1	HydrogelsIBA 01/2022
1	EnzymesIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 05/2021
1	RNA (Ribonucleic Acid)IBA 04/2021
1	Antineoplastic Agents (Antineoplastics)IBA 04/2021
1	GoldIBA 04/2021
1	Cyclophilins (Cyclophilin)IBA 01/2021
1	CateninsIBA 12/2019
1	acylcarnitineIBA 01/2019
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	CarbohydratesIBA 01/2019
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2019
1	ProdrugsIBA 10/2018
1	Cycloserine (Seromycin)FDA Link 01/2018
1	Drug CombinationsIBA 01/2018
1	N-Methylaspartate (NMDA)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	PPAR gammaIBA 01/2018
1	IronIBA 12/2017
1	SulfurIBA 12/2017
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 12/2017

Therapy/Procedure

10	Therapeutics 12/2021 - 04/2002
2	Transplantation 01/2018 - 08/2017
2	Ketogenic Diet 01/2015 - 07/2004
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018